# A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

> **NCT00903565** · — · UNKNOWN · sponsor: **Agendia** · enrollment: 1200 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00903565
- **Lead sponsor:** Agendia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903565, "A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00903565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*